ArticleFrontiers in oncology2022
PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2'-Deoxycytidine.
Di Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleFrontiers in oncology2022
Di Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.